Pulmonary disease among inpatient decedents: Impact of schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 3, 2007, Pages 720-726

  Copeland, Laurel A ^a,b   Mortensen, Eric M ^a,b   Zeber, John E ^a,b   Pugh, Mary Jo ^a,b   Restrepo, Marcos I ^a,b   Dalack, Gregory W ^c,d  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Health Services; Mortality; Respiratory Disorders; Schizophrenia; Veterans

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; FATALITY; FEMALE; HOSPITAL PATIENT; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PNEUMONIA; RACE DIFFERENCE; RISK ASSESSMENT; SCHIZOPHRENIA; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; DEMOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; LUNG DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; VETERANS;

EID: 33947547127     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.01.008     Document Type: Article

References (50)

1. Agha Z., Lofgren R.P., VanRuiswyk J.V., and Layde P.M. Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med 160 21 (2000) 3252-3257 [Nov]
2. Anderson R.N., and Smith B.L. Deaths: leading causes for 2002. National Vital Statistics Report vol. 53(17) (2005) 1-90 Mar
3. Aruna A.S., and Murungi J.H. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient. Ann Pharmacother 39 6 (2005) 1131-1135 [Jun]
4. Blow FC, McCarthy JF, Valenstein M, Austin K, Gillon L. Care for Veterans with Psychosis in the VHA, FY04: 6th Annual National Psychosis Registry Report. Ann Arbor, MI: VA National Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Health Services Research and Development Center of Excellence 2005.
5. Borzecki A.M., Wong A.T., Hickey E.C., Ash A.S., and Berlowitz D.R. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach?. Am J Med Qual 19 5 (2004) 201-206
6. Brown S., Inskip H., and Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 177 (2000) 212-217 [Sep]
7. Casey D.E. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am J Med 118 Suppl 2 (2005) 15S-22S [Apr]
8. Chafetz L., White M.C., Collins-Bride G., and Nickens J. The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Community Ment Health J 41 2 (2005) 169-184 [Apr]
9. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 5 (1987) 373-383
10. Copeland L.A., Zeber J.E., Rosenheck R.A., and Miller A.L. Unforeseen inpatientmortality among veterans with schizophrenia. Med Care 44 2 (2006) 110-116
11. Cradock-O'Leary J., Young A.S., Yano E.M., Wang M., and Lee M.L. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv 53 7 (2002) 874-878 [Jul]
12. Curkendall S.M., Mo J., Glasser D.B., Rose Stang M., and Jones J.K. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 65 5 (2004) 715-720 [Jun]
13. Dalack G.W., Becks L., Hill E., Pomerleau O.F., and Meador-Woodruff J.H. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21 2 (1999) 195-202 [Aug]
14. Daumit G.L., Pratt L.A., Crum R.M., Powe N.R., and Ford D.E. Characteristics of primary care visits for individuals with severe mental illness in a national sample. Gen Hosp Psychiatry 24 6 (2002) 391-395 [Nov-2002 Dec]
15. de Leon J., Dadvand M., Canuso C., White A., Stanilla J., and Simpson G. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 152 3 (1995) 453-455 [Mar]
16. de Leon J., Diaz F.J., Josiassen R.C., Cooper T.B., and Simpson G.M. Does clozapine decrease smoking?. Prog Neuro-Psychopharmacol Biol Psychiatry 29 5 (2005) 757-762 [Jun]
17. Dixon L.B., Kreyenbuhl J.A., Dickerson F.B., Donner T.W., Brown C.H., Wolheiter K., et al. A comparison of Type 2 diabetes outcomes among persons with and without severe mental illnesses. Psychiatr Serv 55 8 (2004) 892-900 [Aug]
18. Dolder C.R., Lacro J.P., and Jeste D.V. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosom Med 65 1 (2003) 156-162 [Jan-2003 Feb]
19. Druss B.G., and Rosenheck R.A. Use of medical services by veterans with mental disorders. Psychosomatics 38 5 (1997) 451-458 [Sep-1997 Oct]
20. Esterberg M.L., and Compton M.T. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Soc Sci Med 61 2 (2005) 293-303 [Jul]
21. Evins A.E., Cather C., Deckersbach T., Freudenreich O., Culhane M.A., Olm-Shipman C.M., et al. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol 25 3 (2005) 218-225 [Jun]
22. Frayne S.M., Halanych J.H., Miller D.R., Wang F., Lin H., Pogach L., et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med 165 22 (2005) 2631-2638 [Dec]
23. George T.P., Vessicchio J.C., Termine A., Bregartner T.A., Feingold A., Rounsaville B.J., et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 52 1 (2002) 53-61 [Jul]
24. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 66 2 (2005) 183-194 [Sep]
25. Goldman L.S. Medical illness in patients with schizophrenia. J Clin Psychiatry 60 Suppl 21 (1999) 10-15
26. Goldman R., Craig T.J., and Lance T. Smoking cessation treatment among a national sample of veteran outpatients (2004), VHA Office of Quality and Performance, Washington, DC Dec
27. Jensen H.H., Godtfredsen N.S., Lange P., and Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J 28 4 (2006) 781-785 [Oct]
28. Kashner T.M. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 36 9 (1998) 1324-1336 [Sep]
29. Kazis L.E., Miller D.R., Clark J., Skinner K., Lee A., Rogers W., et al. Health-related quality of life in patients served by the Department of Veterans Affairs: results from the Veterans Health Study. Arch Intern Med 158 6 (1998) 626-632 [Mar]
30. Kazis L.E., Ren X.S., Lee A., Skinner K., Rogers W., Clark J., et al. Health status in VA patients: results from the Veterans Health Study. Am J Med Qual 14 1 (1999) 28-38 [Jan-1999 Feb]
31. Kermode M., Crofts N., Miller P., Speed B., and Streeton J. Health indicators and risks among people experiencing homelessness in Melbourne, 1995-1996. Aust N Z J Public Health 22 4 (1998) 464-470 [Jun]
32. Klabunde C.N., Reeve B.B., Harlan L.C., Davis W.W., and Potosky A.L. Do patients consistently report comorbid conditions over time? Results from the Prostate Cancer Outcomes Study. Med Care 43 4 (2005) 391-400 [Apr]
33. Liam C.K., and Ong S.B. Neuroleptic malignant syndrome with renal and respiratory complications-a case report. Singapore Med J 31 2 (1990) 182-184 [Apr]
34. Miller DR, Kalman D, Ren XS, Lee AF, Niu Z, Kazis LE. Health Behaviors of Veterans in the VHA: Tobacco Use. Washington DC: Office of Quality and Performance (10Q), Veterans Health Administration, Department of Veterans Affairs, and Center for Health Quality, Outcomes,and Economic Research, Veterans Affairs Medical Center, 2001 Dec. Report No.: 1999 Large Health Survey of VHA Enrollees.
35. Morgan R.O., Teal C.R., Reddy S.G., Ford M.E., and Ashton C.M. Measurement in Veterans Affairs Health Services Research: veterans as a special population. Health Serv Res 40 5 Pt 2 (2005) 1573-1583 [Oct]
36. Newman S.C., and Bland R.C. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 36 4 (1991) 239-245 [May]
37. Nichol K.L., Baken L., and Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 130 5 (1999) 397-403 [Mar]
38. Nishikawa T., Kaneda W., Uegaki A., Koga I., Uchida Y., and Tanaka M. Respiratory dyskinesia: a variety of clinical forms differentially diagnosed by using a spirograph. Clin Neuropharmacol 15 4 (1992) 315-321 [Aug]
39. Pauwels R.A., Buist A.S., Ma P., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): Executive Summary. Respir Care 46 8 (2001) 798-825 [Aug]
40. Pedrelli P., McQuaid J.R., Granholm E., Patterson T.L., McClure F., Beck A.T., et al. Measuring cognitive insight in middle-aged and older patients with psychotic disorders. Schizophr Res 71 2-3 (2004) 297-305 [Dec]
41. Shapiro S.D., and Ingenito E.P. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol 32 5 (2005) 367-372 [May]
42. Sherman C.B. The health consequences of cigarette smoking. Pulmonary diseases. Med Clin North Am 76 2 (1992) 355-375 [Mar]
43. Smith Sehdev A.E., and Hutchins G.M. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 161 2 (2001) 277-284 [Jan]
44. Sokal J., Messias E., Dickerson F.B., Kreyenbuhl J., Brown C.H., Goldberg R.W., et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis 192 6 (2004) 421-427 [Jul]
45. Szeto H.C., Coleman R.K., Gholami P., Hoffman B.B., and Goldstein M.K. Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic. Am J Manag Care 8 1 (2002) 37-43 [Jan]
46. Valenstein M., Copeland L.A., Blow F.C., McCarthy J.F., Zeber J.E., Gillon L., et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 40 8 (2002) 630-639 [Aug]
47. Weaver F.M., Hatzakis M., Evans C.T., Smith B., LaVela S.L., Wallace C., et al. A comparison of multiple data sources to identify vaccinations for veterans with spinal cord injuries and disorders. J Am Med Inform Assoc: JAMIA 11 5 (2004) 377-379 [Sep-2004 Oct]
48. Wilcox P.G., Bassett A., Jones B., and Fleetham J.A. Respiratory dysrhythmias in patients with tardive dyskinesia. Chest 105 1 (1994) 203-207 [Jan]
49. Youssef H.A., and Waddington J.L. Characterization of abnormal respiratory movements in schizophrenic, bipolar and mentally handicapped patients with typical tardive dyskinesia. Int Clin Psychopharmacol 4 1 (1989) 55-59 [Jan]
50. Zimmerman R.K., Santibanez T.A., Janosky J.E., Fine M.J., Raymund M., Wilson S.A., et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices. Am J Med 114 1 (2003) 31-38 [Jan]